Indication
For the treatment of Giant Cell Arteritis (GCA) in adult patients.

Medicine details

Medicine name:
tocilizumab (RoActemra)
SMC ID:
SMC2014
Pharmaceutical company
Roche
BNF chapter
Musculoskeletal and joint diseases
Submission type
Full submission
Status
Advice due date:
10 September 2018
SMC meeting date:
07 August 2018
Patient group submission deadline:
04 June 2018